Aktuelle Ringversuche

Getestete Parameter:

Virusimmunologie - Hantaviren (Ak)

Anti-Hantavirus IgG - Immunoblot, Anti-Hantavirus IgM - Immunoblot, Infektionsstatus einer Hantavirusinfektion (ohne Differenzierung des Serotyps)

Getestete Parameter:

Virusimmunologie - Cytomegalievirus (Ak):

Anti-CMV IgG, Anti-CMV IgG - Avidität, Anti-CMV IgM

Getestete Parameter:

Virusimmunologie - Hepatitis-C-Virus (Ak und HCV Antigen)

Suchtest Anti-HCV bzw. kombiniert Anti-HCV und HCV-Ag

Getestete Parameter:

Virusimmunologie - Hepatitis-B-Virus Programm 2 (Anti-HBc-IgM, HBeAg, Anti-HBe):

Anti-HBc IgM, HBeAg, Anti-HBe

Getestete Parameter:

Virusimmunologie - Hepatitis-B-Virus Programm 1 (HBsAg, Anti-HBs, Anti-HBc)

HBsAg (qualitativ), HBsAg (qualitativ und Angabe in IU/ml), HBsAg (Bestätigungstest), Anti-HBs, Anti-HBc

Getestete Parameter:

Virusimmunologie - HIV-1/HIV-2 (Ak):

Suchtest Anti-HIV-1/Anti-HIV-2 ( 3. und 4. Generation), Bestätigungstest (Blot und anderer Bestätigungstest) Anti-HIV-1/Anti-HIV-2

Getestete Parameter:

Virusimmunologie - Hepatitis-A-Virus (Ak):

Anti-HAV IgG / Anti-HAV gesamt, Anti-HAV IgM

Getestete Parameter:

Bakteriologie (5 Proben)

Gramfärbung, Anzüchtung, Identifizierung und Empfindlichkeitsprüfung von Bakterien

Getestete Parameter:

Immunhämatologie 03 - Thrombozytenimmunologie:

Nachweis thrombozytärer Antikörper

Getestete Parameter:

Ringversuch für Schilddrüsenantikörper im Serum

Anti-TG(TAK), Anti-TPO(MAK), Anti-TSH-Rez(TRAK)

Getestete Parameter:

HbA1c

Getestete Parameter:

Ringversuch für Molekularbiologie, Gruppe 1:

FV-Leiden (F5, NM_000130..., FII g20210a (F2, NM_0005..., MTHFR C677T (MTHFR, NM_0..., MTHFR A1298C (MTHFR, NM_..., PAI-I 4G5G (SERPINE1, NM...,   AAT-PI*S (SERPINA1, NM_0..., AAT-PI*Z (SERPINA1, NM_0..., AAT, Alpha-1-Antitrypsin..., ApoE2 (APOE, NM_000041.4..., ApoE4 (APOE, NM_000041.4..., ApoE, Apolipoprotein E –..., ApoB100 (APOB, NM_000384…, HFE H63D (HFE, NM_000410..., HFE S65C (HFE, NM_000410..., HFE C282Y (HFE, NM_00041..., LCT c-13910t (LCT, NM_00...,  AT3 Cambridge Typ I/II (... CYP3A5*3 (CYP3A5, NM_000..

Getestete Parameter:

Ringversuch für Molekularbiologie, Gruppe 2:

TPMT*2 (TPMT, NM_000367...., TPMT*3B (TPMT, NM_000367..., TPMT*3C (TPMT, NM_000367..., Thiopurine S-methyltrans..., CYP2C8*3 (CYP2C8, NM_000..., CYP2C9*2 (CYP2C9, NM_000..., CYP2C9*3 (CYP2C9, NM_000..., CYP2C9 - 2C9 - Genotypis..., UGT1A1*28 (UGT1A1, NM_00..., DPYD*2A (DPYD, NM_000110..., DPYD*13 (DPYD, NM_000110..., DPYD p.D949V (DPYD, NM_0..., DPYD c.1236G>A (DPYD, NM..., DPD activity score acc. ..., DPD activity score acc. ..., CYP2D6*2-296 (CYP2D6*2, ..., CYP2D6*3 (CYP2D6*3, NM_0..., CYP2D6*4 (CYP2D6*4, NM_0..., CYP2D6*6 (CYP2D6*6, NM_0..., CYP2D6*7 (CYP2D6*7, NM_0..., CYP2D6*8 (CYP2D6*8, NM_0..., CYP2D6*9 (CYP2D6*9, NM_0..., CYP2D6*10 (CYP2D6*10, NM..., CYP2D6*35 (CYP2D6*35, NM..., CYP2D6*41 (CYP2D6*41, NM..., CYP2D6*5 (CYP2D6, Deleti..., CYP2D6*xN (CYP2D6, Dupli..., CYP2C19*2 (CYP2C19, NM_0..., CYP2C19*3 (CYP2C19, NM_0..., CYP2C19*17 (CYP2C19, NM_..., CYP2C19 Genotypisierung HLA B*57:01 (HLA-B, NM_0..., CYP2B6*4 (CYP2B6, NM_000..., CYP2B6*9 (CYP2B6, NM_000..., CYP2B6*6 (NM_000767.5:c...., CYP3A4*22 (CYP3A4, NM_01..., Cyp2D6 Genotyp

Getestete Parameter:

Ringversuch zur quantitativen Bestimmung von Antidepressiva in Serum:

Bupropion, Hydroxybupropion, Milnacipran, Moclobemid, Methylphenidat, Ritalinsäure, Atmoxetin, Tranylcypromin, Vortioxetin

Getestete Parameter:

Doxepin, Nordoxepin, Amitriptylin, Nortriptylin, Trimipramin, Opipramol, Imipramin, Desipramin, Clomipramin, Norclomipramin, Maprotilin